[HTML][HTML] Frequency and associations of adverse reactions of COVID-19 vaccines reported to pharmacovigilance systems in the European Union and the United States

D Montano - Frontiers in public health, 2022 - frontiersin.org
Introduction This study aims to provide a risk assessment of the adverse reactions related to
the COVID-19 vaccines manufactured by AstraZeneca, Janssen, Moderna, and Pfizer …

[HTML][HTML] Description of frequencies of reported adverse events following immunization among four different COVID-19 vaccine brands

A Kant, J Jansen, L van Balveren, F van Hunsel - Drug safety, 2022 - Springer
Introduction The rapid rollout of coronavirus disease 2019 (COVID-19) vaccines for a large
proportion of the population necessitates a strong emphasis on safety. Complementary to …

Adverse reactions of COVID-19 vaccines: a scoping review of observational studies

I Dhamanti, AA Suwantika, A Adlia… - … journal of general …, 2023 - Taylor & Francis
The COVID-19 pandemic had a severe global impact. A range of campaigns and activities,
including vaccines, are being implemented to counteract this pandemic. Using observational …

[HTML][HTML] Adverse events related to COVID-19 vaccines: the need to strengthen pharmacovigilance monitoring systems

S Shrestha, J Khatri, S Shakya, K Danekhu… - Drugs & Therapy …, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a new
species of β-coronavirus genus named severe acute respiratory syndrome coronavirus 2 …

[HTML][HTML] Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases-an ACCESS cohort study

C Willame, C Dodd, CE Durán, R Elbers, R Gini… - Vaccine, 2023 - Elsevier
Abstract Background In May 2020, the ACCESS (The vACCine covid-19 monitoring
readinESS) project was launched to prepare real-world monitoring of COVID-19 vaccines …

Post‐Covid‐19‐vaccination adverse events and healthcare utilization among individuals with or without previous SARS‐CoV‐2 infection

FTT Lai, L Huang, K Peng, X Li… - Journal of Internal …, 2022 - Wiley Online Library
Background Post‐marketing pharmacovigilance data are scant on the safety of Covid‐19
vaccines among people with previous SARS‐CoV‐2 infection compared with ordinary …

[HTML][HTML] Adverse events following immunization with COVID-19 vaccines: a narrative review

B Bhandari, G Rayamajhi, P Lamichhane… - BioMed research …, 2022 - hindawi.com
Numerous COVID-19 vaccines are being administered to people around the world. Adverse
events following immunization (AEFI) with COVID-19 vaccines have been reported by health …

Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study

X Li, A Ostropolets, R Makadia, A Shoaibi, G Rao… - bmj, 2021 - bmj.com
Objective To quantify the background incidence rates of 15 prespecified adverse events of
special interest (AESIs) associated with covid-19 vaccines. Design Multinational network …

Comparison of adverse drug reactions among four COVID‐19 vaccines in Europe using the EudraVigilance database: thrombosis at unusual sites

M Abbattista, I Martinelli… - Journal of Thrombosis and …, 2021 - Wiley Online Library
Background Real‐world experience with adenoviral vector vaccines against COVID‐19
raised some safety concerns. Cases of cerebral vein thrombosis (CVT) associated with …

[HTML][HTML] COVID-19 vaccines adverse events: potential molecular mechanisms

M Lamprinou, A Sachinidis, E Stamoula, T Vavilis… - Immunologic …, 2023 - Springer
COVID-19 is an infectious disease caused by a single-stranded RNA (ssRNA) virus, known
as SARS-CoV-2. The disease, since its first outbreak in Wuhan, China, in December 2019 …